Lupin Says U.S FDA Has Conducted A Pre-Approval Inspection At Manufacturing Facility Located In Somerset, New Jersey, USA
Oct 11 (Reuters) - Lupin Ltd LUPN.NS:
LUPIN: U.S. FDA HAS CONDUCTED A PRE-APPROVAL INSPECTION AT OUR MANUFACTURING FACILITY LOCATED IN SOMERSET, NEW JERSEY, USA
LUPIN: THE U.S. FDA INSPECTION WAS CONDUCTED FROM SEPTEMBER 29 TO OCTOBER 10, 2025 AND CONCLUDED WITH ONE OBSERVATION
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.